The automotive AI camera technology company submitted listing applications to South Korea's technology stock exchange for ...

The South Korean automaker presented strategic plans for electrified vehicle portfolio growth and manufacturing capabilities ...

Regulatory clearance for the engineered immune cell treatment targeting non-blood cancers is expected imminently in the country.

The cell therapy company secured pre-listing funding to advance clinical development of engineered immune treatments for non-blood cancers globally.

The credit insurance provider predicted continued elevation in corporate bankruptcies worldwide as economic pressures persist ...

The Chinese pharmaceutical company granted the South Korean partner exclusive rights to commercialize its GLP-1 receptor agonist Bofanglutide internationally.

The Swiss quantum computing company agreed to list through a special purpose acquisition company transaction valuing the firm ...

The biotechnology company administered its ONC-841 candidate to the initial patient in early-to-mid-stage testing for the neurodegenerative disease.

The laundry service provider secured placement on The Straits Times annual ranking recognizing rapid business expansion.

The Hong Kong conglomerate published annual environmental, social and governance performance documentation linking sustainability to shareholder returns.

The Malaysian asset manager received recognition at the 2026 Lipper Fund Awards, underscoring its fund performance and ...